Part one of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI ...

Eli Lilly, the pharmaceutical giant behind some of the most successful drugs in recent years, has announced plans to invest ...

On Friday, Aquestive Therapeutics, Inc. (NASDAQ:AQST) hosted a virtual investor day highlighting the company’s Anaphylm ...

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...

Incyte Corp's new patent details innovative methods for synthesizing baricitinib, a key rheumatoid arthritis treatment, enhancing pharmaceutical manufacturing processes.

The newest drugs and treatments for rheumatoid arthritis (RA) include Janus kinase (JAK) inhibitors, a Bruton’s tyrosine kinase (BTK) inhibitor, and neurostimulation, among other treatments.

More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

Italy: A recent 24-week study conducted in Italy has yielded promising results regarding the effectiveness and safety of baricitinib for patients with severe alopecia areata (AA). The research, which ...

Read Also: Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries Eczema, also known as atopic dermatitis, is an inflammatory skin condition that can ...

Forty percent also said they took immunosuppressants, including cyclosporine, methotrexate and azathioprine, Chu said, adding that about 15 percent of them also took small molecule targeted drugs, ...